Selected Publications
Gillessen S, Sauvé N, Collette L, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A, Hentrich M, Bokemeyer C, Negaard H, Fankhauser C, Shamash J, Vaughn DJ, Sternberg CN, Heidenreich A, Beyer J; International Germ Cell Cancer Classification Update Consortium.: Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results From the IGCCCG Update Consortium Journal of Clinical Oncology : 2021.
Beyer J, Collette L, Sauvé N, Daugaard G, Feldman DR, Tandstad T, Tryakin A, Stahl O, Gonzalez-Billalabeitia E, De Giorgi U, Culine S, de Wit R, Hansen AR, Bebek M, Terbuch A, Albany C, Hentrich M, Gietema JA, Negaard H, Huddart RA, Lorch A, Cafferty FH, Heng DYC, Sweeney CJ, Winquist E, Chovanec M, Fankhauser C, Stark D, Grimison P, Necchi A, Tran B, Heidenreich A, Shamash J, Sternberg CN, Vaughn DJ, Duran I, Bokemeyer C, Patrikidou A, Cathomas R, Assele S, Gillessen S; International Germ Cell Cancer Classification Update Consortium.: Survival and new prognosticators in metastatic seminoma: results from the IGCCCG-Update Consortium Journal of Clinical Oncology : 2021.
Sun L, Parikh RB, Hubbard RA, Cashy J, Takvorian SU, Vaughn DJ, Robinson KW, Narayan V, Ky B.: Assessment and management of cardiovascular risk factors among US Veterans with prostate cancer JAMA Network Open 4 (2): e210070,2021.
Nead KT, Mitra N, Weathers B, Pyle L, Emechebe N, Pucci DA, Jacobs LA, Vaughn DJ, Nathanson KL, Kanetsky PA: Lower abdominal and pelvic radiation and testicular germ cell tumor risk
PLoS One
15 (11): e0239321,2020.
Haas NB, LaRiviere MJ, Buckingham TH, Cherkas Y, Calara-Nielsen K, Foulk B, Patel J, Gross S, Smirnov D, Vaughn DJ, Amaravadi R, Wellen KE, Savitch SL, Majmundar KJ, Black TA, Yee SS, He M, Min EJ, Long Q, Jones JO, Pal SK, Carpenter EL.: Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
Prostate Cancer Prostatic Disease : 2020.
Trendowski MR, Wheeler HE, El Charif O, Feldman DR, Hamilton R, Vaughn DJ, Fung C, Kollmannsberger C, Einhorn LH, Travis LB, Dolan ME.: Clinical and genome-wide analysis of multiple severe cisplatin-induced neurotoxicities in adult-onset cancer survivors.
Clinical Cancer Research : 2020.
McAndrew NP, Dickson MA, Clark AS, Troxel AB, O'Hara MH, Colameco C, Gallager M, Gramlich K, Zafman K, Vaughn D, Schwartz GK, O'Dwyer PJ, DeMichele A.: Early treatment-related neutropenia predicts response to palbociclib.
British Journal of Cancer 123 (6): 912-918,2020.
Morgan MA, Garratt JM, Vaughn DJ: What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors
Abdominal Radiology (NY) : 2020.
Morgan MA, Garratt JM, Vaughn DJ: What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors.
Abdominal Radiology (NY) : 2020.
Kerns SL, Fung C, Fossa SD, Dinh PC Jr, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB.: Relationship of cisplatin-related adverse health outcomes With disability and unemployment among testicular cancer survivors.
Journal of the National Cancer Institue Cancer Spectrum 4 (4): pkaa022,2020.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-114
3400 Civic Center Blvd
Philadelphia,
PA
19104-4283
Phone: 215-349-8140
Patient appointments: 800-789-7366